Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Masked, Parallel Group, Multi-center, Dose-Finding Comparison of the Safety and Efficacy of ASI-001A 0.5 μg/Day and ASI-001B 0.2 μg/Day Fluocinolone Acetonide Intravitreal Inserts to Sham Injection in Subjects With Diabetic Macular Edema
Brief Summary: This study will evaluate the safety and efficacy of an intravitreal insert of fluocinolone acetonide for the treatment of diabetic macular edema.


Options:
A: Arm Label: Sham injection plus laser; Type: EXPERIMENTAL; Interventions: Behavioral: Sham injection, Procedure: Focal/grid laser | Arm Label: 0.5mg Ranibizumab plus laser; Type: EXPERIMENTAL; Interventions: Drug: Ranibizumab, Procedure: Focal/grid laser | Arm Label: 4-mg Triamcinolone Acetonide plus Laser; Type: ACTIVE_COMPARATOR; Interventions: Drug: Triamcinolone Acetonide, Procedure: Focal/grid laser | Intervention Type: DRUG; Name: Ranibizumab; Assigned to Arm(s): 0.5mg Ranibizumab plus laser | Intervention Type: DRUG; Name: Triamcinolone Acetonide; Assigned to Arm(s): 4-mg Triamcinolone Acetonide plus Laser | Intervention Type: BEHAVIORAL; Name: Sham injection; Assigned to Arm(s): Sham injection plus laser | Intervention Type: PROCEDURE; Name: Focal/grid laser; Assigned to Arm(s): 0.5mg Ranibizumab plus laser, 4-mg Triamcinolone Acetonide plus Laser, Sham injection plus laser
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: fluocinolone acetonide | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Fluocinolone Acetonide | Arm Label: 3; Type: SHAM_COMPARATOR; Interventions: Procedure: Standard of care laser photocoagulation | Intervention Type: DRUG; Name: fluocinolone acetonide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Fluocinolone Acetonide; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Standard of care laser photocoagulation; Assigned to Arm(s): 3
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Laser Photocoagulation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Arm Label: 5; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab | Intervention Type: PROCEDURE; Name: Laser Photocoagulation; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): 5
D: Arm Label: CRVO Observation; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Care | Arm Label: CRVO 1 mg dose triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravitreal triamcinolone injection | Arm Label: CRVO 4 mg dose triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravitreal triamcinolone injection | Arm Label: BRVO standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Care | Arm Label: BRVO 1 mg dose triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravitreal triamcinolone injection | Arm Label: BRVO 4 mg dose triamcinolone acetonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravitreal triamcinolone injection | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): BRVO standard care, CRVO Observation | Intervention Type: DRUG; Name: intravitreal triamcinolone injection; Assigned to Arm(s): BRVO 1 mg dose triamcinolone acetonide, CRVO 1 mg dose triamcinolone acetonide | Intervention Type: DRUG; Name: intravitreal triamcinolone injection; Assigned to Arm(s): BRVO 4 mg dose triamcinolone acetonide, CRVO 4 mg dose triamcinolone acetonide

Answer: B